A Review on "IL-1 Receptor Antagonist Plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis"

被引：0
|
作者：
Anikhindi, Shrihari [1 ]
Anikhindi, Akshay [1 ]
Kumar, Ashish [1 ]
Arora, Anil [1 ]
机构：
[1] Sir Ganga Ram Hosp, Inst Liver Gastroenterol & Pancreaticobiliary Sci, New Delhi, India
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2023年 / 13卷 / 03期
关键词：
THERAPY;
D O I：
10.1016/j.jceh.2023.01.011
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：533 / 535
页数：3
相关论文
共 50 条
  • [21] Cellular senescence is reduced following alcohol cessation in severe alcohol-associated hepatitis
    Rodrigo-Torres, Daniel
    Kilpatrick, Alastair M.
    Atkinson, Stephen R.
    Ferreira-Gonzalez, Sofia
    Tyson, Luke D.
    Vergis, Nikhil
    Thursz, Mark R.
    Martinez-Gili, Laura
    Forbes, Stuart J.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S14 - S14
  • [22] IL-1 receptor antagonist as an aerosol in inflammation
    Ischenko, Alexander M.
    Nikolaev, Boris P.
    Kotova, Tatiana V.
    Vorobeychikov, Eugeny V.
    Konusova, Velentina G.
    Yakovleva, Ludmila Y.
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2007, 20 (04): : 445 - 459
  • [23] IL-1 RECEPTOR ANTAGONIST AND POSTMENOPAUSAL OSTEOPOROSIS
    PACIFICI, R
    VANNICE, JL
    BLOEDOW, DC
    THOMPSON, RB
    KIMBLE, R
    CLINICAL RESEARCH, 1992, 40 (03): : A735 - A735
  • [24] IL-1 receptor antagonist for prevention of severe immune effector cell-associated neurotoxicity syndrome.
    Oliai, Caspian
    Crosetti, Anna
    De Vos, Sven
    Eradat, Herbert
    Mead, Monica Diane
    Larson, Sarah Marie
    Tsai, Steven
    Liu, Annabel
    Khachatrian, Gina
    Hannigan, Christopher
    Yamada, Reiko E.
    Rokni, Neiki
    Timmerman, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Analysis of interleukin (IL)-Iβ IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders
    Libra, M
    Mangano, K
    Anzaldi, M
    Quattrocchi, C
    Donia, M
    Di Marco, R
    Signorelli, S
    Scalia, G
    Zignego, AL
    De Re, V
    Mazzarino, MC
    Nicoletti, F
    ONCOLOGY REPORTS, 2006, 15 (05) : 1305 - 1308
  • [26] The IL-1 system in HIV infection: Peripheral concentrations of IL-1 beta, IL-1 receptor antagonist and soluble IL-1 receptor type II
    Kreuzer, KA
    Dayer, JM
    Rockstroh, JK
    Sauerbruch, T
    Spengler, U
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 54 - 58
  • [27] Investigation of IL-1 Beta, IL-1 Receptor Antagonist and IL-8 Gene Polymorphisms in Patients with Chronic Hepatitis B and C
    Borekci, Gulay
    Karakas Celik, Sevim
    Kandemir, Ozlem
    Aras, Nurcan
    Yalin, Serap
    MIKROBIYOLOJI BULTENI, 2014, 48 (02): : 271 - 282
  • [28] Neutralisation of IL-1 receptor antagonist is associated with increased IL-1 mediated damage in a human in vitro model of GvHD
    Cullup, H
    Wang, XN
    Sviland, L
    Dickinson, AM
    BONE MARROW TRANSPLANTATION, 2004, 33 : S79 - S79
  • [29] Definition and measurement of alcohol-associated insight in early liver transplantation for acute alcohol-associated hepatitis: A systematic review
    Winder, Gerald Scott
    Clifton, Erin G.
    Fernandez, Anne C.
    MacEachern, Mark
    Andrews, Sarah
    Perumalswami, Ponni
    DiMartini, Andrea F.
    Mellinger, Jessica L.
    LIVER TRANSPLANTATION, 2023, 29 (07) : 757 - 767
  • [30] IL-1β, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders
    Tominaga, K
    Habu, M
    Sukedai, M
    Hirota, Y
    Takahashi, T
    Fukuda, J
    ARCHIVES OF ORAL BIOLOGY, 2004, 49 (06) : 493 - 499
12345